AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5
slide-6

Sitared-M 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Sun Pharmaceutical Industries Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitared-M 50/1000 Tablet

Duo-Diabetol 50/1000 tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Duo-Diabetol 50/1000 may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose levels, and concurrent medications. Ingesting the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise regimen is crucial. Lifestyle modifications are integral to diabetes control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; proper recognition and management of hypoglycemia are essential. This medication is not universally suitable. Prior to initiating treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals must consult their physician before use. Drug interactions are possible; disclose all medications to your doctor to ensure treatment safety. Alcohol should be minimized due to its potential to lower blood glucose. Your physician will monitor renal function and blood sugar levels throughout the treatment course.

Uses of Sitared-M 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Sitared-M 50/1000 Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitared-M 50/1000 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Sitared-M 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitared-M 50/1000 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Sitared-M 50/1000 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Sitared-M 50/1000 Tablet works:

Sitared-M 50/1000 tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin responsiveness. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Sitared-M 50/1000 Tablet and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitared-M 50/1000 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitared-M 50/1000 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitared-M 50/1000 Tablets cautiously, potentially requiring dosage modification. Medical supervision is recommended. Sitared-M 50/1000 Tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from using Sitared-M 50/1000 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitared-M 50/1000 Tablet :

Should you forget to take a Sitared-M 50/1000 Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitared-M 50/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitared-M 50/1000 Tablet

Sitared-M 50/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitared-M 50/1000 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), and balance problems. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitared-M 50/1000 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitared-M 50/1000 Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitared-M 50/1000 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sitared-M 50/1000) can rarely cause lactic acidosis (MALA), a serious medical emergency involving high blood lactic acid levels. This risk is increased in patients with kidney disease, the elderly, and heavy alcohol users, hence metformin avoidance in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Sitared-M 50/1000 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. It helps control blood sugar when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitared-M 50/1000 Tablet may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitared-M 50/1000 Tablets are contraindicated in patients with known allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitared-M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitared-M 50/1000) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA—Metformin-associated lactic acidosis). This risk is higher in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitared-M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and balance problems), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitared-M 50/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitared-M 50/1000 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitared-M 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitared-M 50/1000 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitared-M 50/1000) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA – Metformin-associated lactic acidosis). This rare side effect is a reason to avoid this medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitared-M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Sitared-M 50/1000 Tablet
149
MRP 173
13% off